# Lasa Supergenerics Ltd (LASA)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹8.1
Day Change: -0.86%
52W High: ₹18.57
52W Low: ₹5.65
Market Cap: ₹41 Cr

## Valuation
P/E: 2.19
P/B: 0.72
EPS: ₹3.7
Book Value: ₹11.26
Dividend Yield: 0%

## Returns
1Y Return: -28.44%

## Profitability
ROE: 0%
ROCE: -7.05%
Debt/Equity: 0.13
Revenue Growth: -93.3%
Profit Growth: 0%
EBITDA Margin: 8.32%
Operating Margin: -103.72%

## About
Lasa Supergenerics Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Lasa Supergenerics Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Results For Quarter Ended 31St December 2025 13 Feb
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- BSE Filing: Results For Quarter Ended 31St December 2025 13 Feb

## Access
Current tier: anonymous
More history: Register free to see 6 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:03.547Z
Price History Updated: 2026-05-19T01:02:42.934Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-19T01:02:42.934Z
Quant Updated: 2026-05-19T01:02:42.934Z
Sentiment Updated: 2026-05-19T01:02:42.934Z
Financials Status: current
Financials Updated: 2026-05-18T23:08:48.429Z
Financials Last Attempt: 2026-05-18T23:08:48.429Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2018)
Revenue: ₹199 Cr
Operating Profit: ₹46 Cr (OPM 23%)
Net Profit: ₹2 Cr
Tax: ₹2 Cr

## Annual P&L History
Mar 2018: Rev ₹199Cr | PAT ₹2Cr | OPM 23%
Mar 2019: Rev ₹244Cr | PAT ₹12Cr | OPM 17%
Mar 2020: Rev ₹170Cr | PAT ₹-12Cr | OPM 7%

## Balance Sheet (Mar 2018)
Total Assets: ₹228 Cr
Total Liabilities: ₹228 Cr
Borrowings: ₹116 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Omkar Pravin Herlekar, Chairman & MD
- Varsha Pravin Joshi, Chief Financial Officer
- Mitti  Jain C.S., Company Secretary & Compliance Officer
- Anil  Fargade, Senior Accounts Officer
- Sunil  Sitale, Manager of HR & Admin

---
Source: rupiya.io/stocks/lasa
Disclaimer: For research and education only. Not investment advice.